SV

Sanket Vishwanath Sontakke

Active Director Director DIN 10404069
DIN 10404069 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanket Vishwanath Sontakke

Data last updated:

Sanket Vishwanath Sontakke is a Director at Coscutem Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10404069
Primary Designation Director
Industry Pharma
First Appointment 24 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Nov 20232023Active

Board colleagues of Sanket Vishwanath Sontakke

Directorship timeline

Open interactive timeline →
Coscutem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanket Vishwanath Sontakke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanket Vishwanath Sontakke

Sanket Vishwanath Sontakke currently holds 1 directorship: Coscutem Pharmaceuticals Private Limited (Director, since 24 Nov 2023).

Sanket Vishwanath Sontakke was first appointed on 24 Nov 2023 as Director at Coscutem Pharmaceuticals Private Limited.

The current boards of Sanket Vishwanath Sontakke's companies include Dnyaneshwari Shailesh Dalal (Coscutem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available